Results 161 to 170 of about 2,046,439 (266)

Hysteroscopic Retrieval of Retained and Fractured Copper Intrauterine Devices: A Case Series of Three Patients and Literature Review. [PDF]

Cureus
Vijay N, Pathak A, Bhalerao A.
europepmc   +1 more source

Comparison of Mirena and Liletta levonorgestrel intrauterine devices for the treatment of endometrial intraepithelial neoplasia and grade 1 endometrioid endometrial cancer. [PDF]

Gynecol Oncol Rep, 2023
Chaudhari SR, Lai TS, Zakhour M, Myung Shin S, Baltayan A, Tan H, Cohen JG.   +6 more
europepmc   +1 more source

Membranous dysmenorrhea and decidual casts: A scoping review

International Journal of Gynecology &Obstetrics, Volume 175, Issue 2, Page 544-553, November 2026.
Abstract Background Membranous dysmenorrhea, characterized by the expulsion of intact endometrial tissue rather than gradual dissolution during menstruation, occasionally presents as a decidual cast—a complete triangular mold of the uterine cavity. This poorly understood condition is likely underdiagnosed.
Lovisa Brehmer, Hedvig Engberg
wiley   +1 more source

The effect of levonorgestrel-releasing intrauterine devices on acne vulgaris: A prospective cohort study. [PDF]

Int J Gynaecol Obstet
Cao A, Zita S, Kim W, Stevenson EM, Goodman LH, Wang M, Hugh J, Guidry J, Mirhossaini R, Lazorwitz A, Stephen S, Newman S.   +11 more
europepmc   +1 more source

Descriptive study of the real-world, long-term cost estimates and duration of use for hormonal and nonhormonal intrauterine devices using US commercial insurance claims. [PDF]

J Manag Care Spec Pharm, 2023
Nguyen BT, Heyrana K, Ohsfeldt R, Johnston A, Summers K.   +4 more
europepmc   +1 more source

Effectiveness of immersive virtual reality‐based interventions for alleviating peri‐ and post‐procedural pain and anxiety in gynecologic settings: A systematic review and meta‐analysis of randomized controlled trials

International Journal of Gynecology &Obstetrics, Volume 175, Issue 2, Page 565-583, November 2026.
Abstract Background Non‐pharmacological and complementary therapeutic, notably immersive virtual reality‐based interventions (IVR), could alleviate pain and anxiety associated with gynecologic procedures. Objective To evaluate the effectiveness of IVR in reducing peri‐ and post‐procedural pain and anxiety in gynecologic procedures.
Cristina González‐Lara, Marina Piñar‐Lara, Esteban Obrero‐Gaitán, Héctor García‐López, Irene Cortés‐Pérez   +4 more
wiley   +1 more source

Profiles of copper intrauterine devices and levonorgestrel intrauterine systems users in France in 2019: A national observational population-based study. [PDF]

Int J Gynaecol Obstet, 2023
Roland N, Baricault B, Dray-Spira R, Weill A, Duranteau L, Zureik M.   +5 more
europepmc   +1 more source

FIGO statement on emergency contraception

International Journal of Gynecology &Obstetrics, Volume 175, Issue 2, Page 522-525, November 2026.
Abstract Emergency contraception remains an essential component of comprehensive contraceptive care and reproductive autonomy. Despite being safe, highly effective, and associated with almost no absolute medical contraindications or age limits, emergency contraception is often underutilized due to systemic barriers, limited access, persistent ...
Mikaela Koch, Asha Kasliwal, James Kiarie, Nasser Elkholy, Azra Ahsan, Aparna Sridhar   +5 more
wiley   +1 more source

Perceptions of community members and healthcare providers on intrauterine devices: a qualitative study in southern Ethiopia. [PDF]

BMJ Public Health
Dubale S, Tesfaw M.
europepmc   +1 more source

One-year pregnancy and continuation rates after placement of levonorgestrel or copper intrauterine devices for emergency contraception: a randomized controlled trial. [PDF]

Am J Obstet Gynecol, 2023
Kaiser JE, Turok DK, Gero A, Gawron LM, Simmons RG, Sanders JN.   +5 more
europepmc   +1 more source